Contingency Management: What It Is, What the Evidence Shows, and How Rewards Fit Into Recovery

Contingency management, often shortened to CM, is one of the most studied behavioral treatments in addiction care, and one of the least familiar to families. The idea is simple. When a person does something that supports recovery, and that behavior is verified, they get a small, tangible reward right away. Over time, the reward helps the new behavior take hold. This guide explains how CM works, where the research is strongest, where it falls short, and how Accountable's member rewards program, AccountaPoints, relates to it.

What contingency management is

SAMHSA defines CM as a health care intervention in which tangible incentives are given "contingent on objective evidence of change in a specific, incentivized behavior." In practice, a program picks a target behavior, such as a negative drug test or showing up to a treatment session. It checks for that behavior with something objective, like a test result or an attendance record. When the behavior happens, the reward follows quickly. Rewards are usually gift cards, vouchers or small prizes. Some programs use a prize draw, where each verified success earns a chance at a prize of varying size.

The approach comes from behavioral science. Substance use delivers a fast, reliable reward. Early recovery often offers the opposite: benefits that are real but slow, and hard to feel on an ordinary Tuesday. CM puts something immediate and concrete on the other side of the scale while the longer-term rewards of recovery build.

The principles that make it work

SAMHSA's 2025 advisory on CM lays out the features that separate the studied intervention from a loose rewards program:

• Objective verification. The reward depends on evidence, such as a test result, rather than a self-report.

• Immediacy. The reward comes as soon as the behavior is verified. A reward that arrives weeks later loses most of its pull.

• Escalation. The value grows with each consecutive success, so a streak becomes worth protecting.

• Reset. If the target is missed, the value drops back to the starting level and then climbs again with the next success. The reset keeps the incentive meaningful without adding punishment.

These are the rules the research tested. A program that drops them may still be helpful, but it is no longer delivering the intervention that was studied.

What the evidence shows

CM has decades of research behind it. A 2006 meta-analysis in the journal Addiction pooled 47 comparisons from 44 studies and found that CM consistently outperformed the treatments it was compared with, with the largest effects for opioid and cocaine use.

A 2021 systematic review and meta-analysis in JAMA Psychiatry focused on people taking medication for opioid use disorder, drawing on 74 reports and 10,444 participants. Adding CM was associated with less stimulant use, less cigarette smoking and less illicit opioid use, along with better medication adherence and better attendance at therapy.

Stimulants are where CM matters most. There are no FDA-approved medications for methamphetamine or cocaine use disorder. The ASAM/AAAP clinical practice guideline on stimulant use disorder recommends that CM "be a primary component of the treatment plan," a strong recommendation based on high-certainty evidence. Our guides to methamphetamine and cocaine cover what else helps.

The research on alcohol is newer but encouraging, and it matters for care delivered at home. In a 2018 randomized trial, 40 adults with alcohol use disorder took breathalyzer tests remotely with a smartphone and a portable device. Participants rewarded for alcohol-free readings were abstinent on 85% of days, compared with 38% for participants paid the same amount regardless of their results. The study showed that CM does not have to happen in a clinic. For more on how remote testing works, see how sobriety monitoring works.

The limits

CM is not a cure, and the research is candid about its weak spots.

• Effects often fade after rewards stop. A 2025 health technology assessment for New York State Medicaid reviewed trials that followed people for 9 to 12 months after CM ended and found no lasting effect on abstinence once the incentives stopped. That is one reason CM works best inside a longer plan that includes treatment, coaching and peer support.

• Testing windows matter. According to SAMHSA, current breath tests detect alcohol for up to about 12 hours. One breath test cannot confirm a week without drinking, so testing has to be scheduled to match the goal.

• Opioids need a different target. SAMHSA advises against using CM to reward abstinence from opioids, citing testing limitations and overdose safety. For opioid use disorder, CM is better used to reinforce medication adherence and treatment attendance.

• Access has been limited. For years, federal guidance held incentives in SAMHSA-funded programs to $75 per patient per year, far below the amounts used in most studies. In January 2025, SAMHSA raised that limit to $750 per patient per year.

Where contingency management is offered

CM is becoming easier to find. The Veterans Health Administration brought it to more than 90 sites between 2011 and 2015, and 2,844 veterans received CM services between 2018 and 2022. California became the first state to cover CM as a Medicaid benefit through its Recovery Incentives Program, which launched in 2023 and offers 24 weeks of CM for stimulant use disorder followed by six or more months of recovery support services. Washington, Montana, Delaware and Hawaii have also received federal approval for Medicaid CM programs.

If you are looking for formal CM, ask a treatment program directly whether they offer it, which behaviors they reward and how testing works.

How Accountable uses rewards: AccountaPoints

Accountable members earn AccountaPoints for the everyday work of recovery: attending a coaching session, joining a peer group meeting, completing a breathalyzer check or a saliva toxicology screen, finishing a weekly goal, and filling out check-in surveys. Points add up over time and can be redeemed for practical Accountable items, from a phone stand or notebook to a water bottle or backpack.

AccountaPoints borrows the core idea of contingency management: a tangible reward tied to a verified action, given close to the time it happens. Most of what earns points is recorded in the app as it happens, such as a completed test or an attended session, so recognition does not depend on anyone remembering to give it.

It also differs from clinical CM in ways we want to be clear about:

• It rewards engagement, not test results. Members earn points for completing a test, whatever the result. AccountaPoints is not an abstinence-contingent protocol.

• It does not use an escalating schedule with resets. Points accumulate steadily.

• Rewards are small branded items, not cash or gift cards.

• It is a member perk that comes with the program. It is not a treatment on its own, and it is not a reason to enroll.

We built it this way on purpose. Our model centers on showing up: weekly one-on-one recovery coaching, daily peer groups, breathalyzer checks and random saliva screening. AccountaPoints gives members a small, visible marker of that work, week after week. A result that shows alcohol or drug use does not cost a member points. It starts a conversation with their coach about what happened and what comes next.

If you or your treatment team want formal CM for stimulant use, Accountable can work alongside a program that provides it. Coaching and monitoring complement a clinical CM protocol. They do not replace one.

Questions to ask any rewards or CM program

• What behavior earns a reward, and how is it verified?

• How soon after the behavior is the reward given?

• Does the reward grow over time, and what resets it?

• What happens after a positive test?

• How long does the program last, and what support continues after the rewards end?

Common questions

Is contingency management just paying people not to use?

It uses rewards, but they are modest and tied to verified behavior. Research shows the approach changes behavior during treatment, especially for stimulants, which is why ASAM and AAAP recommend it. The point is to build momentum while the slower rewards of recovery, like trust, work and routine, start to take hold.

Does insurance cover contingency management?

Coverage is limited. A handful of state Medicaid programs cover CM for stimulant use disorder, and the VA offers it to eligible veterans. Commercial coverage is uncommon. For Accountable members, AccountaPoints is part of the program at no extra cost. You can check how coverage works in your state.

Is AccountaPoints a form of contingency management?

It is inspired by the same idea but is not a formal CM protocol. AccountaPoints rewards a broad set of engagement activities, like coaching, groups, goals and testing, rather than following an abstinence-contingent schedule. We describe it as a member rewards program, not a treatment.

Can families use rewards at home?

Families can make a real difference by noticing and acknowledging progress. A formal CM program needs objective testing and a consistent schedule, which is hard to run inside a family. If you want to add rewards at home, talk it through with your loved one's coach or clinician first, so rewards support the plan instead of becoming a source of conflict. Our guide on how to help someone with addiction has more ideas.

Sources

1. Substance Abuse and Mental Health Services Administration. Contingency Management for the Treatment of Substance Use Disorders: Enhancing Access, Quality, and Program Integrity for an Evidence-Based Intervention (Advisory, PEP24-06-001). January 2025.

2. Prendergast M, Podus D, Finney J, Greenwell L, Roll J. Contingency management for treatment of substance use disorders: a meta-analysis. Addiction. 2006.

3. Bolívar HA, et al. Contingency Management for Patients Receiving Medication for Opioid Use Disorder: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2021.

4. American Society of Addiction Medicine and American Academy of Addiction Psychiatry. Clinical Practice Guideline on the Management of Stimulant Use Disorder. 2024.

5. Koffarnus MN, Bickel WK, Kablinger AS. Remote Alcohol Monitoring to Facilitate Incentive-Based Treatment for Alcohol Use Disorder: A Randomized Trial. Alcoholism: Clinical and Experimental Research. 2018.

6. New York State Department of Health, Medicaid Evidence Based Benefit Review Advisory Committee. Contingency Management for Stimulant Use Disorder: Health Technology Assessment. April 2025.

7. California Department of Health Care Services. Recovery Incentives Program: California's Contingency Management Benefit.